Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

June 20, 2019June 20, 2019

Orilissa Increases Workplace Productivity in People with Endometriosis, Study Suggests

News

Orilissa (elagolix), a treatment that reduces pain in endometriosis, can also have economic benefits, a study reports. The therapy allowed patients to work more and be more productive, which would ... Read more

June 18, 2019June 18, 2019

Debiopharm, Ipsen Extend Partnership for Patient Access to Decapeptyl

News

The pharmaceutical companies Debiopharm and Ipsen have extended their agreement for the development, manufacturing, and distribution of Decapeptyl (triptorelin), used in the treatment of endometriosis. This partnership, which began in ... Read more

March 14, 2019March 14, 2019

Study in Mice Identifies Gal-3 Protein as Driver of Endometriosis, Potential Therapeutic Target

News

The protein galectin-3 (Gal-3) might play a key role in the development of endometriosis, a study suggests. Moreover, blocking this protein may be a possible treatment strategy. The study, “Galectin-3 ... Read more